Not applicableLooking for participantsNCT06898905What this trial is testingHyperfractionated Dual Equivalent Fractionated Radiation TherapyWho this might be right forDiffuse Large B-Cell Lymphoma Yale University 10
Testing effectiveness (Phase 2)Study completedNCT05322330What this trial is testingClinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin's Lymphoma The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06911710What this trial is testingThe Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic TumorsWho this might be right forLymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)AML (Acute Myelogenous Leukemia)Myeloma Multiple+3 more Tianjin Medical University General Hospital 90
Very early researchNot Yet RecruitingNCT04670055What this trial is testingHumanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple MyelomaWho this might be right forRelapse Multiple MyelomaRefractory Multiple Myeloma Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT01745640What this trial is testingPomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)Who this might be right forMultiple Myeloma University Hospital, Lille 63
Early research (Phase 1)Study completedNCT01689220What this trial is testingSP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaWho this might be right forPeripheral T-cell Lymphoma Solasia Pharma K.K. 6
Early research (Phase 1)Looking for participantsNCT06208735What this trial is testingCLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forB-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more British Columbia Cancer Agency 24
Early research (Phase 1)Looking for participantsNCT06047197What this trial is testingPhase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-cell Lymphoma Beijing Yongtai Ruike Biotechnology Company Ltd 25
Not applicableUnknownNCT02919046What this trial is testingStudy Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in ChildrenWho this might be right forRelapsed or Refractory Neuroblastoma Sinobioway Cell Therapy Co., Ltd. 22
Testing effectiveness (Phase 2)Looking for participantsNCT05319314What this trial is testingLYL273 for Patients With Relapsed or Refractory mCRCWho this might be right forColorectal Cancer Lyell Immunopharma, Inc. 155
Testing effectiveness (Phase 2)Study completedNCT02445248What this trial is testingStudy of Efficacy and Safety of CTL019 in Adult DLBCL PatientsWho this might be right forDiffuse Large B-cell Lymphoma (DLBCL) Novartis Pharmaceuticals 115
Early research (Phase 1)Active Not RecruitingNCT03190278What this trial is testingStudy Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia Cellectis S.A. 29
Testing effectiveness (Phase 2)Study completedNCT02676778What this trial is testingStudy of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell LymphomaWho this might be right forPeripheral T-cell LymphomaCutaneous T-cell Lymphoma Eisai Co., Ltd. 45
Not applicableStudy completedNCT00919425What this trial is testingS9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Ended earlyNCT05886491What this trial is testingGDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forLeukemia Takeda 16
Not applicableLooking for participantsNCT06067347What this trial is testingA Global Study of the PETAL ConsortiumWho this might be right forT-Cell and NK-Cell Neoplasm Massachusetts General Hospital 1,200
Not applicableLooking for participantsNCT06850285What this trial is testingCD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory LymphomaWho this might be right forLymphoma, B-Cell Shanxi Bethune Hospital 15
Early research (Phase 1)Ended earlyNCT02978235What this trial is testingA Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or LymphomaWho this might be right forMultiple MyelomaNonHodgkin Lymphoma Taiho Oncology, Inc. 11
Testing effectiveness (Phase 2)Ended earlyNCT05117008What this trial is testingMaintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple MyelomaWho this might be right forRefractory Multiple MyelomaRelapse Multiple Myeloma Medical College of Wisconsin 1
Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149